Healthcare Executive Passes Out During Weight Loss Drug Announcement
Gordon Findlay, Healthcare Executive of Novo Nordisk, fainted Thursday at the Oval Office during a public announcement on weight loss drugs.
Incident Details
The event, focused on GLP-1 drugs, was interrupted when Findlay lost consciousness. President Donald Trump and Dr. Mehmet Oz quickly turned their attention to him.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," said White House Press Secretary Karoline Leavitt. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Announcement Context
On the same day, President Trump announced a deal with Eli Lilly and Novo Nordisk to make some obesity drugs available to Americans for about $150 per month.
- Multiple speakers were present at the White House event.
- Findlay fainted during the speech of Eli Lilly CEO David Ricks.
- Press was hurried out of the room following the incident.
- Dr. Kennedy left to obtain medical assistance.
- The press conference resumed at 1:29 p.m.
White House Deputy Press Secretary Kush Desai stated that assistance was promptly provided after Findlay’s fainting.
Summary: The sudden fainting of Novo Nordisk's healthcare executive briefly interrupted a significant White House announcement on affordable obesity medications but was quickly managed, allowing the event to continue.
More News
- Man City vs Liverpool - Premier League LIVE: Latest score and updates
- Man City vs Liverpool ref watch: Three decisions Chris Kavanagh got absolutely wrong
- Vanoli: ‘Fiorentina have to go back to basics, a lot of problems to fix’ - Football Italia
- Roma vs Udinese LIVE Score Updates: A Clash That Promises Excitement in Serie A (2-0) | 11/09/2025
- Man City's 3-0 demolition job on Liverpool effectively ends title hope
- VAR's baffling explanation of Virgil van Dijk goal disallowed vs. Man City